RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @DocDrMulasli: IL-6 blokerlar COVID-19 tedavisinde sağkalımı artırabilabilir mi? sorusunun cevabı için retrospektif olarak 21 hastada…
RT @DocDrMulasli: IL-6 blokerlar COVID-19 tedavisinde sağkalımı artırabilabilir mi? sorusunun cevabı için retrospektif olarak 21 hastada…
RT @DocDrMulasli: IL-6 blokerlar COVID-19 tedavisinde sağkalımı artırabilabilir mi? sorusunun cevabı için retrospektif olarak 21 hastada…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
IL-6 blokerlar COVID-19 tedavisinde sağkalımı artırabilabilir mi? sorusunun cevabı için retrospektif olarak 21 hastadaki sonuçlar değerlendirildirilmiş ve IL-6 blokerlarının COVID-19 tedavisi için çözüm sağlamadığı gözlemlenmiş.... https://t.co/v5HYkpEO
The #COVID19 confusion continues!
New research published in @PNASNews assessed the efficacy of tocilizumab in severe patients with #COVID-19, and found it to be an effective treatment to reduce mortality. https://t.co/eHiY4LibIe
!!!
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
Pues con esto se nos está cayendo todo el arsenal que tenemos para el COVID 19...
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @3DiMMUNE: here it is effective but again no control to compare placebo. Effective treatment of severe COVID-19 patients with tocilizum…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
https://t.co/DgcZCdlW6Z Quite familiar with such curing method when I heard the previous research which is conducted by Chinese researchers. such medicine can prevent the Covid-19 related Cytokine Storm Syndrome. Which is the so-called "most effective" met
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
Nevertheless, we should blockade all of IL just in case.
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
RT @EricTopol: Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient ret…
Can IL-6 blockade improve survival for severe #COVID19? https://t.co/kpvl1QwH2J @PNASNews Unfortunately, this 21-patient retrospective report doesn't help settle the matter at all, w/ 2 unpublished RCTs going in either direction https://t.co/U5ac3Az0Ev
tocilizumab is the drug I would want if I got severe Covid!! https://t.co/7IMnmoMuDJ
@prakasia
EFFECTIVE TREATMENT OF SEVERE COVID-19 PATIENTS WITH TOCILIZUMAB https://t.co/RxBYLoph9O
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @emlitofnote: Run. A. Trial. https://t.co/OZg2yzH8Nc
RT @ester0961: ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del rec…
RT @DanielJDrucker: Why randomized trials #COVID19 may help you get old #tocilizumab https://t.co/T8lAnXZks8
RT @RichardConniff: Meanwhile, no one mentions a study issued the same day, in which Chinese researchers report on a drug w/ far more detai…
RT @RichardConniff: Meanwhile, no one mentions a study issued the same day, in which Chinese researchers report on a drug w/ far more detai…
Meanwhile, no one mentions a study issued the same day, in which Chinese researchers report on a drug w/ far more detailed evidence of improvement in all of the 21 patients with severe symptoms they tested. https://t.co/86kjdhi457
Not a placebo controlled trial but interesting nonetheless https://t.co/cXdcVG5ZLK Effective treatment of severe COVID-19 patients with tocilizumab
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @DanielJDrucker: Why randomized trials #COVID19 may help you get old #tocilizumab https://t.co/T8lAnXZks8
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
Que no se cabree el macrófago II: el macrófago contraataca
@TheLancet Make sense using #tocilizumab (immumodulator) in severe #COVID19 https://t.co/DsDOBztDgj Make sense using #remdesivir (anti-viral) in mild/moderate #COVID19 asap. Remdesivir in hi risk COVID19 earlier at HOME should be explored. Too late when ho
@GileadSciences Make sense using #tocilizumab (immumodulator) in severe #COVID19 https://t.co/DsDOBztDgj Make sense using #remdesivir (anti-viral) in mild/moderate #COVID19 asap. Remdesivir in hi risk COVID19 earlier at HOME should be explored. Too late wh
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
@NIAIDNews Make sense using #tocilizumab (immumodulator) in severe #COVID19 https://t.co/DsDOBztDgj Make sense using #remdesivir (anti-viral) in mild/moderate #COVID19 asap. Remdesivir in hi risk COVID19 earlier at HOME should be explored. Too late when ho
Make sense using #tocilizumab (immumodulator) in severe #COVID19 https://t.co/DsDOBztDgj Make sense using #remdesivir (anti-viral) in mild/moderate #COVID19 asap. Remdesivir in hi risk COVID19 earlier at HOME should be explored. Too late when hospitalized.
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
Good grief. This isn’t science, this is just fucking around with their patients. I’ve yelled at people for having bad experiment setups at work thatve been much better than this.
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
Tractament eficaç en pacients amb casos severs de covid-19. El Tocilizumab és un immunosupressor per a l'artritis reumatoide, un anticòs monoclonal que bloqueja les cèl·lules que sobrereaccionen i generen una resposta inflamatòria greu. https://t.co/KYT
Effective treatment of severe COVID-19 patients with tocilizumab https://t.co/oFxPM9HIR2
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @emlitofnote: Run. A. Trial. https://t.co/OZg2yzH8Nc
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
Run. A. Trial.
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
#COVID19 $RHHBY Open-label, uncontrolled data (n=20) from China on tocilizumab (Actemra, anti-IL-6 mAb) treatment were published in @PNASNews: https://t.co/8DHWYIm78S Tocilizumab effectively improved clinical symptoms and repressed the deterioration of se
TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately in severe and critical COVID-19 patients, is an effective treatment to reduce mortality." https://t.co/Oeut5ZzP2H
RT @ester0961: ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del rec…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @alefolgarait: Otro pequeño estudio a favor del tocilizumab https://t.co/CEGYPbJUCz Resultados preliminares publicados en PNAS, mirá @E…
So disheartening to see @PNASNews publishing a non-scientific case series that lacks even a control group, let alone blinding and randomization. And then touting it in a press release. Reminder to the editors: the S stands for science. https://t.co/nNUKrRX
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
Such complete disaster. This was the entire statistical analysis section in the paper's Methods @PNASNews https://t.co/oPDgqG7GC9
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @ester0961: ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del rec…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @W7VOA: Researchers in #China report preliminary evidence supporting an antibody treatment for severe #COVID19. https://t.co/XzRXj575EG
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @Gargotejant: Segons aquest article, un medicament de Roche pensat per a l'artritis reumatoide aniria fetèn per a la COVID-19 El medica…
RT @jonathanrockoff: BREAKING: $RHHBY's Actemra showed signs of helping treat severe Covid-19 patients, according to this @PNASNews study j…
RT @ester0961: ATENCIÓ 🔴 En pacients amb Covid es produeixen respostes inflamatòries greus. Tocilizumab, com a anticòs monoclonal del rec…